GenVec (GNVC) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	4.89M
Short-term investments
Accounts receivable	176K
Prepaid expenses and other	369K
Total current assets	8.94M
Property and equipment, net	230K
Other assets	97K
Total assets	9.27M
Accounts payable	967K
Accrued clinical trial expenses
Accrued other expenses
Unearned revenue
Total current liabilities	1.49M
Unearned revenue
Total liabilities	3.22M
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding in 2011 and 2010	0
Common stock, $0.001 par value; 30,000 shares authorized; 12,918 and 12,908 shares issued and outstanding at June 30, 2011 and December 31, 2010, respectively	23K
Additional paid-in capital
Accumulated other comprehensive income	-1K
Accumulated deficit	-289.1M
Total stockholders' equity	6.05M
Total liabilities and stockholders' equity	9.27M

Entities mentioned with GNVC

View All Entities